Showing results (1531-1540 of 2,081) with videos related to
Sort By:
Pageof 209
Molecular Biology of the Cell|February 22, 2008
The clathrin adaptor Gga2p is a phosphatidylinositol 4-phosphate effector at the Golgi exitLars Demmel, Maike Gravert, Ebru Ercan, et al.Aging|February 18, 2016
Altered lipid metabolism in the aging kidney identified by three layered omic analysisFabian Braun, Markus M Rinschen, Valerie Bartels, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 26, 2021
Barriers to Obtaining a Timely Diagnosis in Human Papillomavirus-Associated Oropharynx CancerEmily E Karp, Linda X Yin, Eric J Moore, et al.European Journal of Nutrition|March 23, 2022
The effect of a natural polyphenol supplement on iron absorption in adults with hereditary hemochromatosisSimone Buerkli, Laura Salvioni, Natalie Koller, et al.Blood Advances|March 4, 2021
Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab eraArushi Khurana, Mattia Novo, Grzegorz S Nowakowski, et al.Journal of Neurosurgery. Spine|November 19, 2016
Lumbar decompression in the elderly: increased age as a risk factor for complications and nonhome dischargeMeghan E Murphy, Hannah Gilder, Patrick R Maloney, et al.Clinical Chemistry and Laboratory Medicine|June 9, 2015
Assessing quality and functionality of DNA isolated from FFPE tissues through external quality assessment in tissue banksParviz Ahmad-Nejad, Angelika Duda, Antje Sucker, et al.Neurology|March 9, 2005
High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screeningJ Hagenah, R Saunders-Pullman, K Hedrich, et al.American Journal of Hematology|September 3, 2022
Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphomaJuan Pablo Alderuccio, Isildinha M Reis, Thomas M Habermann, et al.Hematological Oncology|June 5, 2018
Quality of life at diagnosis predicts overall survival in patients with aggressive lymphomaCarrie A Thompson, Kathleen J Yost, Matthew J Maurer, et al.Pageof 209